These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 450167)

  • 21. [Neurological symptoms of hypomagnesemia].
    Cakici M; van Steenkiste J; Assink JH; Moudrous W
    Ned Tijdschr Geneeskd; 2021 Nov; 165():. PubMed ID: 35129888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cetuximab therapy and symptomatic hypomagnesemia.
    Schrag D; Chung KY; Flombaum C; Saltz L
    J Natl Cancer Inst; 2005 Aug; 97(16):1221-4. PubMed ID: 16106027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aminoglycoside-induced reversible tubular dysfunction.
    Alexandridis G; Liberopoulos E; Elisaf M
    Pharmacology; 2003 Mar; 67(3):118-20. PubMed ID: 12571406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cisplatin-induced hypomagnesemia with seizures: a case report and review of the literature.
    Bellin SL; Selim M
    Gynecol Oncol; 1988 May; 30(1):104-13. PubMed ID: 3284791
    [No Abstract]   [Full Text] [Related]  

  • 25. Incomplete distal renal tubular acidosis in hypomagnesemia-dependent hypocalcemia.
    Passer J
    Arch Intern Med; 1976 Apr; 136(4):462-6. PubMed ID: 1267554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypocalcemia secondary to hypomagnesemia in a patient with Crohn's disease.
    Mukai A; Yamamoto S; Matsumura K
    Clin J Gastroenterol; 2015 Feb; 8(1):22-5. PubMed ID: 25475137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gentamicin effects on urinary electrolyte excretion in healthy subjects.
    Elliott C; Newman N; Madan A
    Clin Pharmacol Ther; 2000 Jan; 67(1):16-21. PubMed ID: 10668849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parathyroid hormone secretion and responsiveness to parathyroid hormone in primary hypomagnesemia.
    Garty R; Alkalay A; Bernheim JL
    Isr J Med Sci; 1983 Apr; 19(4):345-8. PubMed ID: 6853131
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Foscarnet-induced severe hypomagnesemia and other electrolyte disorders.
    Gearhart MO; Sorg TB
    Ann Pharmacother; 1993 Mar; 27(3):285-9. PubMed ID: 8384030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug-induced secondary hyperaldosteronism in patients with pulmonary tuberculosis.
    Holmes AM; Hesling CM; Wilson TM
    Q J Med; 1970 Apr; 39(154):299-315. PubMed ID: 5449594
    [No Abstract]   [Full Text] [Related]  

  • 31. Acquired bartter-like syndrome associated with gentamicin administration.
    Chou CL; Chen YH; Chau T; Lin SH
    Am J Med Sci; 2005 Mar; 329(3):144-9. PubMed ID: 15767821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tetany in association with gentamicin therapy.
    Beatty OL; Campbell NP; Neely RD
    Ulster Med J; 1989 Apr; 58(1):108-10. PubMed ID: 2773167
    [No Abstract]   [Full Text] [Related]  

  • 33. [Asymptomatic hypokalemia and hypomagnesemia with renal cation loss (Gitelman syndrome)].
    Pistor K; Heemann K; Olbing H
    Monatsschr Kinderheilkd; 1987 Jun; 135(6):340-2. PubMed ID: 3614231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathogenesis of hypocalcemia in primary hypomagnesemia: normal end-organ responsiveness to parathyroid hormone, impaired parathyroid gland function.
    Suh SM; Tashjian AH; Matsuo N; Parkinson DK; Fraser D
    J Clin Invest; 1973 Jan; 52(1):153-60. PubMed ID: 4345201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperphosphatemia, hypocalcemia and increased serum potassium concentration as distinctive features of early hypomagnesemia in magnesium-deprived mice.
    Ortega B; MacWilliams JR; Dey JM; Courtright VB
    Magnes Res; 2015 Dec; 28(4):126-35. PubMed ID: 26878252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Symptomatic hypomagnesemia in children.
    Tsau YK; Tsai WY; Lu FL; Tsai WS; Chen CH
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1998; 39(6):393-7. PubMed ID: 9926514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proton pump inhibitor use for 12 months is not associated with changes in serum magnesium levels: a prospective open label comparative study.
    Bahtiri E; Islami H; Hoxha R; Gashi A; Thaçi K; Karakulak Ç; Thaçi S; Qorraj Bytyqi H
    Turk J Gastroenterol; 2017 Mar; 28(2):104-109. PubMed ID: 28082254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tetany and rhabdomyolysis due to surreptitious furosemide--importance of magnesium supplementation.
    Brucato A; Bonati M; Gaspari F; Colussi G; Giachetti M; Zoppi F; Ruggerone ML
    J Toxicol Clin Toxicol; 1993; 31(2):341-4. PubMed ID: 8492347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proton pump inhibitors and symptomatic hypomagnesemic hypoparathyroidism.
    Fatuzzo P; Portale G; Scollo V; Zanoli L; Granata A
    J Nephrol; 2017 Apr; 30(2):297-301. PubMed ID: 27206762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypomagnesemic hypokalemia and hypocalcemia: clinical and laboratory characteristics.
    Elisaf M; Milionis H; Siamopoulos KC
    Miner Electrolyte Metab; 1997; 23(2):105-12. PubMed ID: 9252977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.